These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1703345)

  • 1. Infections in adult liver transplant patients under FK 506 immunosuppression.
    Alessiani M; Kusne S; Martin M; Jain A; Abu-Elmagd K; Moser J; Todo S; Fung J; Starzl T
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1501-3. PubMed ID: 1703345
    [No Abstract]   [Full Text] [Related]  

  • 2. [Opportunistic infections in patients with collagen disease].
    Tanaka Y; Saito K
    Nihon Naika Gakkai Zasshi; 2004 Aug; 93(8):1654-9. PubMed ID: 15384698
    [No Abstract]   [Full Text] [Related]  

  • 3. Early trials with FK 506 as primary treatment in liver transplantation.
    Todo S; Fung JJ; Demetris AJ; Jain A; Venkataramanan R; Starzl TE
    Transplant Proc; 1990 Feb; 22(1):13-6. PubMed ID: 1689886
    [No Abstract]   [Full Text] [Related]  

  • 4. [Complications of hematopoietic stem cell transplantation and the treatment: infections].
    Ishida Y; Sugawara T
    Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1344-50. PubMed ID: 16097590
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiology and risk factors for late infection in solid organ transplant recipients.
    Cervera C; Fernández-Ruiz M; Valledor A; Linares L; Antón A; Ángeles Marcos M; Sanclemente G; Hoyo I; Cofán F; Ricart MJ; Pérez-Villa F; Navasa M; Pumarola T; Moreno A
    Transpl Infect Dis; 2011 Dec; 13(6):598-607. PubMed ID: 21535336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potent immunosuppressive effect of FK 506 in orthotopic liver transplantation in primates.
    Monden M; Gotoh M; Kanai T; Valdivia LA; Umeshita K; Endoh W; Nakano Y; Kawai M; Ohzato H; Ukei T
    Transplant Proc; 1990 Feb; 22(1):66-71. PubMed ID: 1689904
    [No Abstract]   [Full Text] [Related]  

  • 7. Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.
    Fung JJ; Todo S; Tzakis A; Demetris A; Jain A; Abu-Elmaged K; Alessiani M; Starzl TE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):14-21. PubMed ID: 1703682
    [No Abstract]   [Full Text] [Related]  

  • 8. Infectious complications of pediatric liver transplantation under FK 506.
    Green M; Tzakis A; Reyes J; Nour B; Todo S; Starzl TE
    Transplant Proc; 1991 Dec; 23(6):3038-9. PubMed ID: 1721352
    [No Abstract]   [Full Text] [Related]  

  • 9. Infections during a randomized trial comparing cyclosporine to FK 506 immunosuppression in liver transplantation.
    Kusne S; Fung J; Alessiani M; Martin M; Torre-Cisneros J; Irish W; Ondick L; Jain A; Abu-Elmagd K; Takaya S
    Transplant Proc; 1992 Feb; 24(1):429-30. PubMed ID: 1371626
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical approach to viral and fungal infections in the renal transplant patient.
    Tolkoff-Rubin NE; Rubin RH
    Semin Nephrol; 1992 Jul; 12(4):364-75. PubMed ID: 1410863
    [No Abstract]   [Full Text] [Related]  

  • 11. Prophylaxis of opportunistic infections in individuals infected with HIV.
    Klein RS
    AIDS; 1989; 3 Suppl 1():S161-73. PubMed ID: 2514733
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppression withdrawal for treatment of severe infections in liver transplantation.
    Massarollo PC; Mies S; Abdala E; Leitão RM; Raia S
    Transplant Proc; 1998 Jun; 30(4):1472-4. PubMed ID: 9636598
    [No Abstract]   [Full Text] [Related]  

  • 13. Perioperative infection in liver transplant recipients under a quadruple immunosuppressive protocol.
    Pirsch JD; Armbrust MJ; Stratta RJ; D'Alessandro AM; Sollinger HW; Belzer FO; Kalayoglu M; Maki DG
    Transplant Proc; 1989 Jun; 21(3):3559. PubMed ID: 2662531
    [No Abstract]   [Full Text] [Related]  

  • 14. Infectious disease trends among immunocompromised hosts.
    Young B; Tambyah PA
    Singapore Med J; 2012 Apr; 53(4):223-9; quiz 230. PubMed ID: 22511041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections in liver transplantation: risk factors and strategies for prevention.
    Kibbler CC
    J Hosp Infect; 1995 Jun; 30 Suppl():209-17. PubMed ID: 7560952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infectious complications in liver transplant in Italy: current status and prospectives].
    Viscoli C; Dimitri P; Di Domenico S; Mannelli S; Dodi F; Veroni L;
    Recenti Prog Med; 2001 Jan; 92(1):16-31. PubMed ID: 11260965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral management of the patient with end-stage liver disease and the liver transplant patient.
    Douglas LR; Douglass JB; Sieck JO; Smith PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Jul; 86(1):55-64. PubMed ID: 9690246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update in infectious diseases in liver transplant recipients.
    Huprikar S
    Clin Liver Dis; 2007 May; 11(2):337-54. PubMed ID: 17606211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK 506 and orthotopic liver transplantation in the rat.
    Isai H; Painter DM; Sheil AG
    Transplant Proc; 1990 Oct; 22(5):2125-6. PubMed ID: 1699329
    [No Abstract]   [Full Text] [Related]  

  • 20. Notes on FK 506.
    Starzl TE; Fung J; Todo S; Tzakis A
    Transplant Proc; 1991 Aug; 23(4):2178-9. PubMed ID: 1714647
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.